|Articles|August 1, 2012
- Pharmaceutical Executive-08-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - August 2012
Piramal Pivots for Growth
Advertisement
Articles in this issue
over 13 years ago
Country Report: Mexicoover 13 years ago
Sunny Outlook for Biopharm 2020?over 13 years ago
The Phrase that Playsover 13 years ago
Planning that Thousand Year FutureNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Is FDA Streamlining Regulations in the Biosimilar Space?
2
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
3
Carvykti Displays Sustained Remissions in Early Use for Relapsed or Refractory Multiple Myeloma
4
When Borders Become Bottlenecks: How Pharma Should Adapt to the New Geopolitical Lens
5
